Skip to main content

WHO Guideline Update Targets Medicalized FGM and Strengthens Survivor Care

3 min read
640 words
Share:

A new set of guidelines from the World Health Organization aims to curb the rising trend of medicalized female genital mutilation (FGM) and to improve care for survivors. Health experts view this as a crucial step toward ending FGM globally, with focus on health, legal, and ethical implications when health professionals are involved.

FGM refers to procedures that intentionally injure the female genital organs for non-medical reasons. The World Health Organization estimates that more than 200 million girls and women alive today have undergone FGM, with millions more at risk each year. Disturbingly, recent research shows a surge in FGM performed by doctors, nurses, or midwives. While some communities view medicalized FGM as safer, global health authorities and women’s rights advocates agree there is no safe form of FGM, and medicalization perpetuates gender inequality and violence. Research and guidance from leading health institutions underscore this stance.

The updated guidelines reaffirm that FGM, whether done by traditional practitioners or licensed clinicians, violates the rights of girls and women and has no health benefits. Short-term risks include heavy bleeding, extreme pain, and infections; long-term consequences range from persistent infections and childbirth complications to sexual dysfunction and lasting psychological trauma. The guidance also emphasizes better training for healthcare workers to resist pressure to perform FGM and to support the health and wellbeing of survivors.

Experts warn that medicalization does not make FGM safer; it lends the practice a veneer of legitimacy. As one reproductive health expert noted, involvement by health professionals breaches medical ethics and exploits public trust. The guidance calls on governments, professional bodies, and health institutions to prohibit any health personnel from performing or facilitating FGM. It also urges comprehensive education campaigns to address myths and gender norms that sustain the practice.

Thailand, while not among the countries with the highest FGM prevalence, remains connected to diverse communities across Southeast Asia and to the country’s public health policy. As a regional medical hub, Thailand bears responsibility to uphold medical ethics and protect vulnerable groups. Health authorities and medical educators can weave the new recommendations into gynecology, obstetrics, and mental health training. Thailand’s Ministry of Public Health has long framed clinical practice around patient dignity and ethics, and advocates call for clearer policies to address FGM in both private and public healthcare settings.

Culturally, FGM touches on broader themes of tradition, ritual, and social expectations found in various societies. Thai health experts encourage distinguishing cultural practices from the harms identified by international bodies. World Health Organization guidance emphasizes clear health and human rights standards. Global and regional conversations on gender, health, and bodily autonomy often gain momentum around events like the International Day of Zero Tolerance for FGM, which fosters dialogue in Thailand and the ASEAN region.

Looking ahead, the WHO guidelines are expected to influence regional policy reviews, professional training, and cross-border cooperation on patient rights. Continuous monitoring will be essential as awareness grows and attitudes shift. The COVID-19 era has also highlighted risks to girls at increased vulnerability due to disruptions in education and protective services.

For Thai readers and policymakers, the clear message is to ensure all health professionals refuse involvement in FGM and to guarantee survivors receive comprehensive, compassionate care. The guidelines offer a framework for strengthening ethics and gender equity across Thai healthcare. Parents, educators, and community leaders are urged to promote discussions that challenge harmful practices, empower girls, and support survivors without stigma.

For practical guidance, healthcare professionals can consult the WHO guidelines on FGM and collaborate with national medical councils to strengthen reporting and prevention mechanisms. Community organizations and educators are encouraged to engage in multi-sector campaigns that involve law enforcement, social services, and mental health supports to assist at-risk groups and survivors. Upholding the dignity and rights of girls and women in Thailand requires sustained, cross-sector collaboration aligned with global efforts to end FGM.

Related Articles

2 min read

WHO Issues Stricter Guidelines to End Medicalized FGM and Support Survivors in Asia

news sexual and reproductive health

A new set of urgent recommendations from the World Health Organization aims to curb the rise of medicalized female genital mutilation (FGM) and strengthen care for survivors. The guidance, released April 28, 2025, marks a significant step in the global effort to eradicate FGM and protect girls’ health and rights.

FGM involves partial or total removal of external female genitalia for non-medical reasons and carries serious health risks and human-rights violations. As more procedures are reported to be carried out by healthcare professionals—an trend known as medicalization—the WHO calls for stronger legal and policy actions to discourage this practice and to expand survivor support services. Health experts emphasize that no form of FGM is safe or ethical, regardless of the setting or provider.

#fgm #womenshealth #medicalization +7 more
2 min read

Thai flu vaccine guidance: focus on safety, not fear of ingredients

news health

A U.S. federal advisory panel advising the CDC recommended that flu vaccines in the United States be available in single-dose, thimerosal-free formats. If adopted, this would standardize vaccines and address public concerns about ingredients. The issue holds global relevance for Thailand’s immunization programs and public confidence in vaccination.

Thimerosal has long sparked debate over mercury exposure and vaccine safety. The advisory panel, refreshed under new leadership, placed the question of thimerosal at the forefront of its agenda. The move reflects public demand for clearer policies rather than evidence of harm and aligns with the FDA’s position that thimerosal has a long history of safe use as a preservative.

#vaccines #flushot #publichealth +7 more
3 min read

Global vaccination progress stalls, prompting urgent action for Thai health policy

news health

A landmark study published in The Lancet warns that after five decades of steady gains, childhood vaccination coverage is stalling or declining worldwide. The analysis draws on 50 years of country-level data and highlights a troubling rise in “zero-dose” children—those missing even the most basic vaccines. Inequalities, lingering COVID-19 disruptions, and increasing vaccine misinformation are contributing to uneven progress, according to the study led by researchers at the University of Washington’s Institute for Health Metrics and Evaluation and supported by the Gates Foundation and Gavi.

#health #vaccination #children +6 more

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making decisions about your health.